QleanAir renews six cleanroom leases, sells two cleanroom design contracts, sells a cleanroom design and build contract. The closed contracts are worth approximately $1.1M.
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Industri |
| Industri | Industriprodukter |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
QleanAir AB (publ.), a leading provider of solutions for clean indoor air has through its U.S. subsidiary QleanAir Scandinavia Inc., signed agreements with hospitals in Delaware, New York, and Ohio totaling more than $1.1 million. The projects are with two existing integrated delivery network (IDN) customers and one new IDN customer.
QleanAir is dedicated to helping its customers protect people, products, and processes through cleanrooms that meet and exceed USP guidelines and maintain a compliant state of control. To that end, QleanAir has renewed six leases worth approximately $450,000 with a large IDN in New York. The renewal will be recognized by the end of 2025. In addition, the same customer purchased a cleanroom design and build contract worth approximately $458,000. That project is expected to be built in Q2 of 2026.
In addition, QleanAir sold a cleanroom design contract to a leading nonprofit health system serving Northern Virginia and the Washington, D.C. metropolitan area worth $151,000 and expected to be finalized in Q1 2026.
Lastly, QleanAir closed a design contract with a large IDN in Ohio. The design contract is valued at approximately $52,000 and expected to be finalized in Q1 2026.
“We are pleased to partner with these Integrated Delivery Networks by delivering a high-performance cleanroom solution that directly supports their growing compounding needs and scales in harmony with their missions of innovation, quality compliance, and compassionate care for their servicing communities. QleanSpace cleanroom solutions provide health systems with environmental control and adaptability to bring compounded therapies from pharmacy to patient with safety and efficiency.
QleanAir anticipates that this will be the first of several cleanroom projects with the new health system, as both parties explore a deeper collaborative partnership,” says Amanda Myers, Chief Commercial Officer of QleanAir Scandinavia Inc.